This study aimed to investigate whether PC-OxPL neurotoxicity extends to SOD1-associated ALS and if it can be mitigated using an AAV-delivered anti-PC-OxPL scFv, PC-OxPL-VecTab®. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.